top of page


Peer-reviewed journal articles for which I provided medical writing support

Wong CW, Evangelou C, Sefton KN, et al. PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models. Nat Commun. 2023;14(1):5983. doi:10.1038/s41467-023-41737-1 Fisher TB, Saini G, Ts R, et al. Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer. Breast Cancer Res. 2024;26:12. doi:10.1186/s13058-023-01752-y Garlapati C, Joshi S, Bhattarai S, et al. PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer. Cell Death Dis. 2023;14(1):12. doi:10.1038/s41419-022-05539-5 Dasgupta A, Gangai S, Narayan R, Kapoor S. Mapping the lipid signatures in COVID-19 infection: Diagnostic and therapeutic solutions. J Med Chem. 2023;66(21):14411-14433. doi:10.1021/acs.jmedchem.3c01238 Kaur J, Chandrashekar DS, Varga Z, et al. Whole-exome sequencing reveals high mutational concordance between primary and matched recurrent triple-negative breast cancers. Genes. 2023; 14(9):1690. doi:10.3390/genes14091690 Skowronska-Krawczyk D. Hallmarks of aging: causes and consequences. AgingBio, 2023;1:1–3. doi:10.59368/agingbio.20230011 Bhattarai S, Saini G, Li H, et al. Predicting neoadjuvant treatment response in triple-negative breast cancer using machine learning. Diagnostics. 2024;14(1):74. doi:10.3390/diagnostics14010074 Majmudar SP. Long-term effectiveness and safety of omalizumab in a pediatric patient with severe persistent asthma: A case report. Research Square; 2023. doi: 10.21203/ Xu Q, Kaur J, Wylie D, et al. A case series exploration of multi-regional expression heterogeneity in triple-negative breast cancer patients. Int J Mol Sci. 2022;23(21):13322. doi:10.3390/ijms232113322 Luningham JM, Seth G, Saini G, et al. Association of race and area deprivation with breast cancer survival among Black and White women in the state of Georgia. JAMA Netw Open. 2022;5(10):e2238183. doi:10.1001/jamanetworkopen.2022.38183 Lu S, Cheng Y, Huang D, et al. Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321). Ther Adv Med Oncol. 2022;14:17588359221105020.  doi:10.1177/17588359221105020 Kaur J, Chandrashekar DS, Varga Z, et al. Distinct gene expression profiles of matched primary and metastatic triple-negative breast cancers. Cancers (Basel). 2022;14(10):2447. doi:10.3390/cancers14102447 Sugita BM, Rodriguez Y, Fonseca AS, et al. MiR-150-5p overexpression in triple-negative breast cancer contributes to the in vitro aggressiveness of this breast cancer subtype. Cancers (Basel). 2022;14(9):2156. doi:10.3390/cancers14092156 Mei WJ, Mi M, Qian J, Xiao N, Yuan Y, Ding PR. Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review. Front Immunol. 2022;13:1019582. doi:10.3389/fimmu.2022.1019582 Mao L, Qi Z, Zhang L, Guo J, Si L. Immunotherapy in acral and mucosal melanoma: Current status and future directions. Front Immunol. 2021;12:680407.  doi:10.3389/fimmu.2021.680407 Adhyapak P, Dong W, Dasgupta S, Dutta A, Duan M, Kapoor S. Lipid clustering in mycobacterial cell envelope layers governs spatially resolved solvation dynamics. Chem Asian J. 2022;17(11):e202200146. doi:10.1002/asia.202200146 Xiong A, Wang J, Zhou C. Immunotherapy in the first-line treatment of NSCLC: Current status and future directions in China. Front Oncol. 2021;11:757993.  doi:10.3389/fonc.2021.757993 Henderson F, Johnston HR, Badrock AP, et al. Enhanced fatty acid scavenging and glycerophospholipid metabolism accompany melanocyte neoplasia progression in zebrafish. Cancer Res. 2019;79(9):2136-2151. doi:10.1158/0008-5472.CAN-18-2409 Grees M, Sharbi-Yunger A, Evangelou C, et al. Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. Oncoimmunology. 2018;7(7):e1445457. doi:10.1080/2162402X.2018.1445457 Karapetsas A, Tokamani M, Evangelou C, Sandaltzopoulos R. The homeodomain transcription factor MEIS1 triggers chemokine expression and is involved in CD8+ T-lymphocyte infiltration in early stage ovarian cancer. Mol Carcinog. 2018;57(9):1251-1263. doi:10.1002/mc.22840

Conference coverage

For a more comprehensive list, please visit my MuckRack profile

Feature articles

For a more comprehensive list, please visit my MuckRack profile

bottom of page